Lv12
68 积分 2024-11-02 加入
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
21天前
已完结
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
21天前
已完结
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
24天前
已完结
Subgroups and Special Populations in Heart Failure Clinical Trials
24天前
已完结
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
24天前
已完结
Functional and Symptomatic Clinical Trial Endpoints
24天前
已关闭
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
24天前
已完结
Heart failure endpoints in Food and Drug Administration pivotal trials
24天前
已完结
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
28天前
已完结
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
28天前
已完结
皖公网安备34019202002308
